Pharmaceutical consumption of antibacterials for systemic use in Spain 2004-2017

Consumption of antibacterials for systemic use per 1,000 inhabitants per day in Spain from 2004 to 2017

by Beatriz Sevilla, last edited Sep 5, 2019
Pharmaceutical consumption of antibacterials for systemic use in Spain 2004-2017 This statistic displays the consumption of antibacterials for systemic use in Spain from 2004 to 2017. In 2017, the defined daily dosage of antibacterials for systemic use in Spain amounted to 17,2 per 1,000 inhabitants per day.
Show more

Consumption of antibacterials for systemic use per 1,000 inhabitants per day in Spain from 2004 to 2017

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Global pharmaceutical industry"
  • Overview
The most important statistics
  • Companies and products
  • Top companies by revenue
  • R&D, patents, new products
  • Outlook
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statista Accounts: Access All Statistics. Starting from $588 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.